NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CLEAR STREET LLC | 05/15/2025 | 65.76 K | $13.50 K | 0.15% | 0.35% |
| WARBERG ASSET MANAGEMENT LLC | 05/09/2025 | 10.00 K | $2.05 K | -44.25% | 0.05% |
| UBS GROUP AG | 05/13/2025 | 2.84 K | $582 | 2,922.34% | 0.02% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NeuroSense Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
CLEAR STREET LLC: 65,759
Warberg Asset Management LLC: 10,000
UBS Group AG: 2,841
CITADEL ADVISORS LLC: 0
Empery Asset Management, LP: 160,000
0.42% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 238.60 K shares in the last 24 months. This purchase volume represents approximately $186.11 K in transactions.